24 slides from Hyphens Pharma International's earnings presentation, Aug 18, 2020
Slide 1: Hyphens Pharma International Limited Results Briefing 2Q2020
Hyphens Pharma International Limited Results Briefing 2Q2020 SGX: 1J5, Bloomberg: HYP:SP
Slide 2: Disclaimer
DISCLAIMER This presentation has been prepared by Hyphens Pharma International Limited (the "Company" and, together with its subsidiaries, the "Group"). This content in this presentation is being furnished to you on a confidential basis and solely for your information and neither this presentation n
Slide 3: Business Highlights
BUSINESS HIGHLIGHTS
Slide 4: Investing for Growth: Broader geographical footprint
INVESTING FOR GROWTH 1 • Establishing a broader geographical footprint Bangladesh Hong Kong Oman Philippines Myanmar Vietnam Cambodia Malaysia Brunei Singapore Indonesia
Slide 5: Partnership with SUTL HK
PARTNERSHIP WITH SUTL HK Appointment of SUTL HK as exclusive distributor of Ocean Health® supplements. In Hong Kong, Macau and Duty-Free Channels in China
Slide 6: Investing for Growth: Investment in proprietary brands
INVESTING FOR GROWTH 2• Investment in proprietary brands
Slide 7: Acquisition of CG210
ACQUISITION OF CG210® + CG 210® is a globally renowned & patented topical botanical hair growth-promoting agent + Hyphens has acquired the rights, titles and interests in the trademarks of CG 210® for Singapore & Malaysia + New brand ownership adds to our Proprietary Brands business segment + Inclus
Slide 8: Acquisition of CG210
ACQUISITION OF CG210® Hyphens will be promoting to More than Manufactured in France medical professionals in 2 million units have been sold Singapore & Malaysia, as well worldwide as in retail outlets in Malaysia + CG 210® Women lotion, + CG 210® Men lotion, + CG 210® Forte Lotion, and + CG4S Shampo
Slide 9: An advanced emollient with pH balanced formulation
An advanced emollient with pH balanced formulation with ~~~~~ Patent pending in 13 other countries/ region
Slide 10: New Ceradan Launches
NEW CERADAN LAUNCHES Ceradan® Ceradan® Hand Lotion Sanitiser Gentle Cleanser
Slide 11: New Ocean Health Launches
NEW OCEAN HEALTH LAUNCHES Omega-3 + Vitamin D Omega-3 Liquid Iron Powder
Slide 12: CSR Activities
CSR ACTIVITIES Ceradan® National Day + HCP Gratitude CSR Campaign
Slide 13: Financial Highlights
FINANCIAL HIGHLIGHTS
Slide 14: 1.1 Quarterly Revenue
1.1 QUARTERLY REVENUE S$’000 1H20: 61,640 1H19: 56,006 35,000 32,737 31,441 30,699 30,199 30,000 29,002 27,004 10,134 25,000 10,210 11,403 9,662 9,730 9,742 20,000 3,821 3,589 4,512 3,638 4,655 15,000 3,426 10,000 18,782 15,634 16,900 16,025 15,383 13,836 5,000 0 1Q2019 2Q2019 3Q2019 4Q2019 1Q2020 2
Slide 15: 1.2 Segment Revenue
1.2 SEGMENT REVENUE Business Segments Geography Malaysia 7% Medical Others hypermart & 8% Specialty digital; 34% Singapore pharma principals; 1H2020 50% Proprietary 51% Vietnam brands; 15% 35% Malaysia 6% Medical hypermart & Others digital; 35% Specialty 6% pharma 1H2019 Singapore Proprietary princi
Slide 16: 2.1 Quarterly Profit After Tax
2.1 QUARTERLY PROFIT AFTER TAX S$’000 2,500 1H20: 4,282 2,000 1H19: 3,064 1,500 1 2,124 2,158 1,000 1,801 1,635 1,665 1,429 500 0 1Q2019 2Q2019 3Q2019 4Q2019 1Q2020 2Q2020
Slide 17: 2.2 Profit Margins
2.2 PROFIT MARGINS 36.0% 35.0% 34.0% 33.0% 32.0% 31.0% FY2017 FY2018 FY2019 1H2020 GP margin 32.8% 33.7% 35.7% 34.2% 10.0% 9.0% 8.0% 7.0% 6.0% 5.0% 4.0% FY2017 FY2018 FY2019 1H2020 Recurring EBITDA margin 7.2% 7.4% 8.5% 9.2% PBT margin 6.4% 5.8% 6.7% 8.4% PAT margin 5.4% 4.5% 5.5% 6.9%
Slide 18: Financial Position & Cash Flow
3 FINANCIAL POSITION & CASH FLOW S$’000 30 Jun 2020 31 Dec 2019 Total assets 86,481 80,131 Cash & cash equivalents 26,088 26,165 Total liabilities 38,735 36,055 Financial liabilities 818 300 Total equity 45,268 44,076 NAV per share (cents) 15.07 14.67 S$’000 1H2020 1H2019 Cashflow from operating act
Slide 19: Intangible Assets
4 INTANGIBLE ASSETS Source: Intangible Assets Stocktake Report 2020 for Hyphens by IPOS International and EverEdge Global under the IDEAS Programme
Slide 20: Intangible Assets
4 INTANGIBLE ASSETS + Intangible assets (“IA”) are more than registrable intellectual property (“IP”) like trademarks & patents + Also includes trade secrets, know-hows, copyrights and even about the value of the data we have accumulated over the years + Often overlooked by investors as these are ei
Slide 21: Share Performance
SHARE PERFORMANCE
Slide 22: Share Price & Volume
0.15 0.2 0.25 0.3 0.35 0.4 0.45 0.5 0.55 0.6 0.65 2/01/20 - 10,000,000 20,000,000 30,000,000 40,000,000 50,000,000 60,000,000 70,000,000 9/01/20 2/01/20 16/01/20 $0.215 9/01/20 23/01/20 16/01/20 30/01/20 23/01/20 6/02/20 30/01/20 13/02/20 6/02/20 20/02/20 13/02/20 27/02/20 20/02/20 5/03/20 FTSE ST C
Slide 23: Latest Research Report
LATEST RESEARCH REPORT Hyphens Pharma International Ltd Building channels to establish business longevity SINGAPORE | HEALTHCARE | INITIATION Exclusive distributorship of Specialty Pharmaceutical products confers high margins and. strong customer loyalty. Expansion into both online and offline retai
Slide 24: Hyphens Pharma International Limited contact details
Hyphens Pharma International Limited (SGX: 1J5) 16 Tai Seng Street, Level 4, Singapore 534138 www.hyphensgroup.com